All Work

Chris Lange

Is This the Sunesis Resurrection?

On Monday, Sunesis made an announcement that it would be making a presentation regarding its drug candidates vosaroxin and cytarabine.

Chris Lange · 12 years ago

Juno Therapeutics Files for IPO

Juno Therapeutics has filed with the U.S. Securities and Exchange Commission (SEC) for an initial public offering.

Chris Lange · 12 years ago

What Licensing Imetelstat Will Mean for Geron

Geron hasannounced that it entered into an exclusive worldwide license and collaboration agreement with Janssen Biotech to develop and commercialize imetelstat.

Chris Lange · 12 years ago

Smart Sand Partners Files for IPO

Smart Sand Partners has filed with the U.S. Securities and Exchange Commission (SEC) for an initial public offering.

Chris Lange · 12 years ago

Virgin America IPO Ready for Takeoff

Virgin America set its price as $23 for its initial public offering Friday morning. Over 13 million shares were registered.

Chris Lange · 12 years ago

Applied Materials Hurt on Outlook

Applied Materials reported its fourth-quarter and full-year earnings Thursday after the market close.

Chris Lange · 12 years ago

Intrepid Aviation Files for IPO

Intrepid Aviation has filed with the U.S. Securities and Exchange Commission (SEC) for an initial public offering.

Chris Lange · 12 years ago